Drugmaker Gilead Sciences announced an $11 billion investment to expand its U.S. manufacturing capabilities, aiming to boost production capacity and job growth, the San Francisco Business Times reports.
Browsing: Gilead
Drugmaker Gilead Sciences announced an $11 billion investment to expand its U.S. manufacturing capabilities, aiming to boost production capacity and job growth, the San Francisco Business Times reports.